GPT and Thrombocytopenia: Adverse events observed in >10% of the 12W-RDI <80% patients were lymphocytopenia, anemia, thrombocytopenia, fatigue, increased total bilirubin, increased AST (aspartate transaminase)/ALT (alanine transaminase), increased serum creatinine, and electrolytes disorders.